Missouri HB 2052: Adds provisions relating to pharmaceutical cost transparency.

Status: Referred: Health and Mental Health Policy(H) (as of 2020-05-15)

State: Missouri · Session: 2020 · Bill: HB 2052

Sponsors: Sain, Matt

View Missouri HB 2052 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.